WV
W Anthony Vernon

W Anthony Vernon insider trades: NovoCure (NVCR) stock buys and sales

NovoCure Last trade Jun 2, 2026 92 Form 4 filings
$46K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2006
11
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where W reports to the SEC

and 5 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 2, 2026NVCR↓ Sell$46K
Jun 3, 2025NVCR↓ Sell$17K
Jun 4, 2024NVCR↓ Sell$23K
Aug 29, 2019NVCR↓ Sell$9.1M
Apr 17, 2017AXON↑ Buy$1000K
Dec 14, 2015MDVN↑ Buy$610K
Mar 15, 2013MDVN↓ Sell$2.8M
Jun 15, 2012MDVN↓ Sell$8.5M
Oct 30, 2006MDV↑ Buy$51K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NVCR insiders

Open-market trades in the last 12 months

About W Anthony Vernon's insider trades

W Anthony Vernon is an insider at NovoCure (NVCR). Since Oct 30, 2006, W has reported 3 open-market purchases worth $1.7M and 6 sales worth $20.4M on SEC Form 4. In the last 12 months: 1 sale ($46K).

Their filings also include grants and awards (62 filings), option exercises (16 filings), shares withheld for taxes (11 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.